Soma Ray Email

VP, Head Translational Biomarkers . Dyne Therapeutics

Current Roles

Employees:
248
Revenue:
$17.5M
About
Dyne was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to fulfill this mission.
Dyne Therapeutics Address
1560 Trapelo Road
Waltham, MA
United States

Past Companies

Dyne TherapeuticsVice President, Head of Translational Biomarkers
Vertex PharmaceuticalsSenior Director, Head of Clinical Biomarkers
BiogenDirector, Global Biomarker Discovery & Development